263
Participants
Start Date
March 27, 2019
Primary Completion Date
March 26, 2021
Study Completion Date
December 8, 2023
Tislelizumab
200 mg intravenously (IV) once every 3 weeks (Q3W)
Placebo
Placebo to match tislelizumab (administered intravenously Q3W)
Gemcitabine
1 gram per square meter of body surface area (g/m\^2) on Day 1 and day 8 of each cycle, administered as an IV infusion within 30 minutes, for 4 to 6 cycles
Cisplatin
80 milligrams per square meter of body surface area (mg/m\^2) on Day 1 of each cycle, administered as an IV infusion for over 4 hours if possible or with proper infusion time based on local clinical guidelines or clinical practice and according to the treating physician's clinical judgment, for 4 to 6 cycles.
National Cheng Kung University Hospital, Tainan City
Ramathibodi Hospital Mahidol University Hematology, Bangkok
Srinagarind Hospital (Khon Kaen University), Muang
Veterans General Hospital Taichung, Taichung
Changhua Christian Hospital, Changhua
Maharaj Nakorn Chiang Mai Hospital (Chiang Mai University), Muang
Songklanagarind Hospital (Prince of Songkhla University), Hat Yai
Beijing Cancer Hospital, Beijing
Harbin Medical University Cancer Hospital, Harbin
Affiliated Zhongshan Hospital of Fudan University, Shanghai
Shanghai East Hospital, Shanghai
Affiliated Hospital of Nantong University, Nantong
Anhui Provincial Hospital, Hefei
Zhejiang Cancer Hospital, Hangzhou
The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang
Fujian Cancer Hospital, Fuzhou
The First Affiliated Hospital of Xiamen University, Xiamen
Chongqing Cancer Hospital, Chongqing
Chongqing Three Gorges Central Hospital, Chongqing
Changsha Central Hospital, Changsha
Hunan Cancer Hospital, Changsha
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Hubei Cancer Hospital, Wuhan
Sun Yat Sen Memorial Hospital, Sun Yat Sen University (North), Guangzhou
Cancer Center of Guangzhou Medical University, Guangzhou
Sun Yat Sen University Cancer Center, Guangzhou
Guangdong Provincial Peoples Hospital, Guangzhou
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou
Cancer Hospital of Shantou University Medical College, Shantou
The Fifth Affiliated Hospital Sun Yat Sen University, Zhuhai
Affiliated Hospital of Guangdong Medical University, Zhanjiang
The Peoples Hospital of Zhongshan City, Zhongshan
The Peoples Hospital of Guangxi Zhuang Autonomous Region, Nanning
The Tumor Hospital Affiliated to Guangxi Medical University, Nanning
Hainan General Hospital, Haikou
Sichuan Cancer Hospital and Institute, Chengdu
West China Hospital, Sichuan University, Chengdu
Lead Sponsor
BeiGene
INDUSTRY